<DOC>
	<DOCNO>NCT01405807</DOCNO>
	<brief_summary>Overview : This open label , randomize , multi-centre study enroll treat 24 patient refractory AAV . Aims : To determine clinical response severe adverse event rate associate alemtuzumab therapy among patient relapse refractory ANCA associate vasculitis ( AAV ) . Hypothesis : Treatment alemtuzumab induces sustain remission AAV reduce immunosuppressive steroid exposure .</brief_summary>
	<brief_title>Alemtuzumab ANCA Associated Refractory Vasculitis</brief_title>
	<detailed_description />
	<mesh_term>Vasculitis</mesh_term>
	<mesh_term>Systemic Vasculitis</mesh_term>
	<mesh_term>Granulomatosis Polyangiitis</mesh_term>
	<mesh_term>Microscopic Polyangiitis</mesh_term>
	<mesh_term>Alemtuzumab</mesh_term>
	<criteria>1 . A diagnosis AAV , accord standardize definition 2 . Active vasculitis least one severe three non severe item BVAS/WG activity ( equivalent BVAS/WG &gt; 3 ) 3 . Previous therapy either cyclophosphamide methotrexate , combination prednisolone least 3 month . 1 . Age le 18 great 60 year 2 . Creatinine &gt; 150Î¼mol/l ( 1.7mg/dl ) 3 . Total white count &lt; 4x109/l lymphocyte count &lt; 0.5x109/l , IgG &lt; 5g/L , neutrophil count &lt; 1.5x109/l . 4 . Severe lung haemorrhage hypoxia ( &lt; 85 % room air ) 5 . Severe gastrointestinal , central nervous system cardiac vasculitis 6 . Previous therapy : 1 . Alemtuzumab time 2 . IVIg , infliximab , etanercept , adalimumab , abatacept , antithymocyte globulin plasma exchange past three month 3 . Rituximab within past 6 month 7 . Intensive care unit requirement 8 . Active infection HIV , hepatitis B hepatitis C infection require parenteral longterm oral antibiotic 9 . History ITP platelet count screen 50,000 x 106/l 10 . Pregnancy inadequate contraception premenopausal woman 11 . Breast feed 12 . Any condition judge investigator would cause study detrimental patient . 13 . Any multisystem autoimmune disease include Churg Strauss angiitis , systemic lupus erythematosus , antiGBM disease cryoglobulinaemia 14 . Any previous current history malignancy ( resect basal cell carcinoma )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>July 2011</verification_date>
	<keyword>Vasculitis</keyword>
	<keyword>ANCA</keyword>
	<keyword>Refractory</keyword>
</DOC>